Literature DB >> 18193265

Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens.

Stephanie C Joachim1, Jan Reichelt, Simone Berneiser, Norbert Pfeiffer, Franz H Grus.   

Abstract

BACKGROUND: The aim of this study was to gain more information about the possible immunological mechanisms in glaucoma. We analyzed the complex autoantibody patterns against human optic nerve antigens in sera of patients with glaucoma and tried to identify important antigens.
METHODS: Sera of 133 patients were included: healthy control subjects (n = 44), primary open-angle glaucoma (n = 44), and normal tension glaucoma patients (n = 45). The sera were tested against Western blots of human optic nerve, and antibody bands were visualized with chloronaphthol. IgG antibody patterns were analyzed by multivariate statistical techniques, and the most significant antigens were identified by mass spectrometry (Maldi-TOFTOF).
RESULTS: All subjects, even healthy ones, showed different and complex antibody patterns. Glaucoma groups showed specific up- and down-regulations of antibody reactivities compared to the control group. The multivariate analysis of discriminance found significant differences (P < 0.05) in IgG antibody profiles against human optic nerve antigens between both glaucoma groups and healthy subjects. The identified antigens include: myelin basic protein (up-regulated in the POAG group), glial fibrillary acidic protein (down-regulated in the glaucoma groups), and vimentin (down-regulated in the glaucoma groups in comparison to controls).
CONCLUSIONS: Using human optic nerve antigen, we were able to demonstrate that complex IgG autoantibody patterns exist in sera of patients with glaucoma. Large correlations between the given and our previous studies using bovine optic nerve antigens could be seen. Furthermore, anti-myelin basic protein antibodies, which can also be detected in patients with multiple sclerosis, were found in sera of glaucoma patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193265     DOI: 10.1007/s00417-007-0737-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  51 in total

Review 1.  A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma.

Authors:  N N Osborne; J Melena; G Chidlow; J P Wood
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  Immunoglobulins and Antibodies.

Authors:  Alexander Ya. Kulberg
Journal:  Russ J Immunol       Date:  1999-10

3.  Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein.

Authors:  B M Stuart; N A Gregson
Journal:  Br J Rheumatol       Date:  1998-12

4.  Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma.

Authors:  M B Wax; G Tezel; I Saito; R S Gupta; J B Harley; Z Li; C Romano
Journal:  Am J Ophthalmol       Date:  1998-02       Impact factor: 5.258

5.  Changes in the expression of specific Müller cell proteins during long-term retinal detachment.

Authors:  G P Lewis; P A Erickson; C J Guérin; D H Anderson; S K Fisher
Journal:  Exp Eye Res       Date:  1989-07       Impact factor: 3.467

6.  Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.

Authors:  Franz H Grus; Stephanie C Joachim; Kai Bruns; Karl J Lackner; Norbert Pfeiffer; Martin B Wax
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Complex autoantibody repertoires in patients with glaucoma.

Authors:  Franz H Grus; Stephanie C Joachim; Esther M Hoffmann; Norbert Pfeiffer
Journal:  Mol Vis       Date:  2004-02-25       Impact factor: 2.367

9.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.

Authors:  H J Schluesener; R A Sobel; C Linington; H L Weiner
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

10.  Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients.

Authors:  Ikuyo Maruyama; Yoko Ikeda; Mitsuru Nakazawa; Hiroshi Ohguro
Journal:  Tohoku J Exp Med       Date:  2002-07       Impact factor: 1.848

View more
  34 in total

1.  Biomarkers for glaucoma: from the lab to the clinic.

Authors:  N Von Thun Und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.

Authors:  Qiong J Ding; Amy C Cook; Alina V Dumitrescu; Markus H Kuehn
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-19       Impact factor: 4.799

Review 3.  Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review.

Authors:  Bengi Ece Kurtul; Pinar Altiaylik Ozer
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

Review 4.  The immune response in glaucoma: a perspective on the roles of oxidative stress.

Authors:  Gülgün Tezel
Journal:  Exp Eye Res       Date:  2010-08-13       Impact factor: 3.467

5.  Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions.

Authors:  Stephanie C Joachim; Christine Mondon; Oliver W Gramlich; Franz H Grus; H Burkhard Dick
Journal:  J Mol Neurosci       Date:  2013-10-03       Impact factor: 3.444

6.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

7.  Normal versus high tension glaucoma: a comparison of functional and structural defects.

Authors:  Oraorn Thonginnetra; Vivienne C Greenstein; David Chu; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2010-03       Impact factor: 2.503

Review 8.  A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2013-02-05       Impact factor: 21.198

9.  Relationship between retinal morphological findings and autoantibody profile in primary Sjögren's syndrome.

Authors:  Jee Myung Yang; Hwan Heo; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2014-06-03       Impact factor: 2.447

Review 10.  Immune regulation toward immunomodulation for neuroprotection in glaucoma.

Authors:  Gülgün Tezel
Journal:  Curr Opin Pharmacol       Date:  2012-10-19       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.